C57BL/6JCya-Hsd17b6em1/Cya
Common Name
Hsd17b6-KO
Product ID
S-KO-08902
Backgroud
C57BL/6JCya
Strain ID
KOCMP-27400-Hsd17b6-B6J-VA
When using this mouse strain in a publication, please cite “Hsd17b6-KO Mouse (Catalog S-KO-08902) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Hsd17b6-KO
Strain ID
KOCMP-27400-Hsd17b6-B6J-VA
Gene Name
Product ID
S-KO-08902
Gene Alias
17betaHSD9, Hsd17b9, Rdh8
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 10
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000219183
NCBI RefSeq
NM_001359377
Target Region
Exon 3~6
Size of Effective Region
~7.5 kb
Overview of Gene Research
Hsd17b6, encoding 17-beta-hydroxysteroid dehydrogenase type 6, catalyzes the synthesis of androsterone and estrone-steroid hormones [2]. It is also involved in maintaining the equilibrium of 5α-dihydrotestosterone (DHT) in the prostate [1]. The SREBP/SCAP/INSIG complex-related pathway seems to be associated with Hsd17b6, and it may play a role in lipid metabolism and steroid homeostasis, which are crucial for normal physiological function [1]. Genetic models, such as gene knockout mouse models, can be used to study its functions.
In a mouse model with Hsd17b6 deletion in the liver (HLKO), hepatic deletion of Hsd17b6 does not affect diet-induced fatty liver disease in terms of fat accumulation, inflammation, and hepatic fibrosis, though its expression is enriched in the liver and correlated with fatty liver disease [2]. In C57BL/6 and NONcNZO10/LtJ T2D mice, hepatic expression of Hsd17b6 and a mutant defective in androgen metabolism improved glucose intolerance, reduced hepatic triglyceride content, and delayed type 2 diabetes (T2D) development by inhibiting SREBP maturation via binding to the SREBP/SCAP/INSIG complex, independent of its sterol oxidase activity [1].
In conclusion, Hsd17b6 is involved in steroid hormone synthesis and lipid-related metabolic regulation. Mouse models, like the HLKO model, have shown that Hsd17b6 is dispensable for diet-induced fatty liver disease, while in T2D mouse models, it plays a role in delaying T2D development. These findings contribute to understanding its functions in metabolic-related diseases and suggest its potential as a therapeutic target for T2D [1,2].
References:
1. Wei, Fengxiang, Gu, Yan, He, Lizhi, Neira, Sandra Vega, Tang, Damu. 2023. HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation. In Metabolism: clinical and experimental, 145, 155631. doi:10.1016/j.metabol.2023.155631. https://pubmed.ncbi.nlm.nih.gov/37330135/
2. Yuan, Delong, Bai, Nan, Zhu, Qihan, Wang, Jianqing, Chen, Yali. 2025. Hepatic HSD17B6 is dispensable for diet-induced fatty liver disease in mice. In Biochemistry and biophysics reports, 41, 101924. doi:10.1016/j.bbrep.2025.101924. https://pubmed.ncbi.nlm.nih.gov/39896111/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.